Local drug delivery in periodontics: A strategic intervention

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue 4, 2012, Pages 30-34

  Dodwad, Vidya ^a   Vaish, Shubhra ^a   Mahajan, Aakriti ^a   Chhokra, Mehak ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; CHLORHEXIDINE GLUCONATE; CLARITHROMYCIN; DOXYCYCLINE; HERBACEOUS AGENT; LIPOSOME; METRONIDAZOLE; MICROSPHERE; MINOCYCLINE; NANOCAPSULE; NANOPARTICLE; NANOSPHERE; POLYGLACTIN; POLYGLYCOLIC ACID; TETRACYCLINE; TRIPOLYPHOSPHATE;

ANTIMICROBIAL THERAPY; CAMPYLOBACTER RECTUS; CLINICAL EFFECTIVENESS; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SAFETY; EMULSION; GEL; HUMAN; IN VITRO STUDY; MEDICINAL PLANT; MICELLE; MINIMUM INHIBITORY CONCENTRATION; PERIODONTICS; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; REVIEW; SCALE UP; SUSTAINED DRUG RELEASE; TANNERELLA FORSYTHENSIS; TOOTH BRUSHING; TREATMENT DURATION; TREATMENT PLANNING;

EID: 84870931682     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Highfield J. Diagnosis and classification of periodontal disease Aust Dental J: 2009:54(s1); S11-S26.
2. Haffajee AD, Socransky SS. Microbial etiological agents of destructive periodontal disease. Periodontol 2000:1994; 78-111.
3. Moore JWEC, Moore LVH. The bacteria of periodontal diseases, Periodontol 2000:1994: 66-77.
4. Baehni PC: Supportive care of the periodontal patient. Curr Opin Periodontol; 1997: 151-157.
5. Suomi, JD, West JD, Chang JJ, McClendon BJ. The effect of controlled oral hygiene procedures on the progression of periodontal disease in adults: radiographic findings. J Periodontol 1971; 42: 562-564.
6. Abdellaouia KS, Castionib NV, Gurnya R. Local delivery of antimicrobial agents for the treatment of periodontal diseases. Eur J Pharm Biopharm; 2000: 83-99.
7. Adriens PA, Boever JA, Loesche WJ. Bacterial invasion in root cementum and radicular dentin of periodontally diseased teeth in humans. J Periodontol:1988; 59: 222-230.
8. Gordon J, Walker C, Lamster I, West T, Socransky S, Seiger M, Fasciano R, Efficacy of Clindamycin Hydrochloride in refractory periodontitis-12-month results. J Periodontol 1985; 56: 75-80.
9. Slots J. Selection of antimicrobials agents in periodontal therapy. J Periodont Res 2002; 37:389-398.
10. Mombelli A, Van Winkelhoff AJ. The systemic use of antibiotics in periodontal therapy, in: N.P. Lang, T. Karring, J. Lindhe (Eds.), Proceedings of the Second European Workshop on Periodontology, Quintessence, London, 1997, pp. 38-77.
11. Vandekerckhove BNA, Quirynen M, Van Steenberghe D. The use of Tetracycline-containing controlled release fibers in the treatment of refractory periodontitis: J Periodontol 1997; 68:353-361.
12. Needleman IG. Controlled drug release in Periodontics: A review of new therapies. Br Dent J 1991; 170: 405-408.
13. Noyan U, Yilmaz S, Kuru B, Kadir T, Acar O, Buget E. A clinical and microbiological evaluation of systemic and local metronidazole delivery in adult periodontitis patients. J Clin Periodontol 1997; 24: 158-165.
14. Goodson J. Antimicrobial strategies for treatment of periodontal diseases. Periodontol 2000: 1994; 5:142-168.
15. Position paper: The role of controlled drug delivery for periodontitis. J Periodontol 2000; 71:125-140.
16. Goodson JM, Offenbacher S, Farr DH, Hogan PE. Periodontal disease treatment by local drug delivery. J Periodontol 1985; 4: 265-272.
17. Maurizio S, Tonetti. The topical use of antibiotics in periodontal pockets., in: N.P. Lang, T. Karring, J. Lindhe (Eds.), Proceedings of the Second European Workshop on Periodontology, Quintessence, London, 1997, pp. 109-132.
18. Maheshwari M, Miglani G, Mali A, Paradkar A, Yamamura S, Kadam S. Development of Tetracycline-Serratiopeptidase-Containing Periodontal Gel: Formulation and Preliminary Clinical Study; AAPS Pharm Sci Tech 2006; 7 (3) Article 76:E162-171.
19. Schwach K, Loup PJ, Castioni N, Mombelli A, Baehni P, Barr J et al. Bioerodible Injectable Poly(ortho ester) for Tetracycline Controlled Delivery to Periodontal Pockets: Preliminary Trial in Humans; AAPS Pharm Sci 2002; 4 (4) article 20:1-7.
20. Lowenguth RA, Chin I, Caton JG, Cobb CM, Drisko CL, Killoy WJ et al. Evaluation of periodontal treatment using controlled release tetracycline fibers. J Periodonol 1995; 66:700-707.
21. Goodson JM, Hogan R Dunham S. Clinical responses following periodontal treatment by local drug delivery. J Periodontol 1985; 56:81-87
22. Sanz M, Serrano C, Garcia C, Echievarria C, O'Connor A. Clinical and microbiological efficacy of tetracycline fiber therapy in relapsing periodontal sites during supportive periodontal therapy. J Dent Res 1997; 76(Spec. Issue): 153 (Abstr. 1116).
23. Drisko CL, Cobb CM, Killoy WJ, Michalowicz BS, Pihlstrom BL, Lowenguth RA et al. Evaluation of periodontal treatments using controlled-release tetracycline fibers. Clinical response. J Periodontol 1995; 66:692-699.
24. Newman MG, Kornman KS, Doherty FM. A 6-month multicentre evaluation of adjunctive tetracycline fiber therapy used in conjunction with scaling and root planing in maintenance patients: Clinical results. J Periodontol 1994; 65:685-691.
25. Kerry G. Tetracycline-loaded fibers as adjunctive treatment in periodontal disease, J Am Dent Assoc 1994; 125:1199-1203.
26. Michalowicz BS, Pihlstrom BL, Drisko CL, Cobb CM, Killoy WJ, Caton JG et al. Evaluation of periodontal treatments using controlled-release tetracycline fibers: Maintenance response. J Periodontol 1995; 66:708-715.
27. Killoy WJ, Rapley JW, Drisko CL. Single and repeated tetracycline fiber treatment vs periodontal maintenance. J Dent Res 1996; 75(Spec. Issue):153 (Abstr. 1136).
28. Preshow PM. Host response modulation in Periodontics. Periodontol 2000:2008; 48:92-110.
29. Polson AM, Garrett S, Stoller NH, Bandt CL, Hanes PJ, Killoy WJ et al. Multi-center comparative evaluation of subgingivally delivered sanguinarine and doxycycline in the treatment of Periodontitis. II. Clinical results. J Periodontol 1997; 68:119-126.
30. Borden LC, Walker CB, Stone C, Mankodi S., Godowski K.C., Southard H. Microbiota effects following sustained release subgingival delivery of doxycycline. J Dent Res 1997; 76(Spec. Issue): 153 (Abstr. 1114).
31. Garrett S, Adams D, Bandt C, Beiswanger B, Bogle BC, Caton J et al. Two multicenter clinical trials of subgingival doxycycline in the treatment of Periodontitis. J Dent Res 1997; 76(Spec. Issue):153 (Abstr. 1113).
32. Akula S, Chava V. Minocyclines in periodontal therapy; J Indian Soc Periodontol 2000; 3: 49-51.
33. Vandekerckhove BN, Quirynen M, V Steenberghe. The use of locally delivered minocycline in the treatment of chronic periodontitis- A review of the literature. J Clin Periodontol 1998; 25: 964-968.
34. Van Steenebergh D, Bercy P, Kohl J. Subgingival Minocycline Hydrochloride ointment in moderate to severe chronic adult periodontitis a randomised double blind, vehicle controlled multicenter study. J Periodontol 1993; 64:637-644.
35. Pragati S, Ashok S, Kuldeep S. Recent advances in periodontal drug delivery systems. Int J Drug Del 2009; 1: 1-14.
36. Jeffcoat M, Bray KS, Cianico SG, Dentino AR, Fine DH, Gordon JM, et al. Adjunctive use of a subgingival controlled-release Chlorhexidine chip reduces probing depth and improves attachment level compared with scaling and root planing alone. J Periodontol 1998; 69:989-997.
37. Soskolne WA, Heasman PA, Stabholz A, Smart GJ, Palmer M, Flashner M, et al. Sustained local delivery of Chlorhexidine in the treatment of Periodontitis: a multicenter study. J Periodontol 1997; 68:32-38.
38. NandaKumar P.K. Local Drug Delivery-Periocol in Periodontics. Trends Biomater Artif Organs 2006; 19(2);74-80.
39. Chhina K, Bhatnagar R. Local drug delivery. Indian J Dent Sci 2012; 4: 166-69.
40. Greenstein G, Polson A. The Role of Local Drug Delivery in the Management of Periodontal Diseases: A Comprehensive Review. J Periodontol 1998; 69:507-520.
41. Sapna N, Vandana KL. Evaluation of Hyaluronan gel (Gengigel®) as a topical applicant in the treatment of gingivitis. J Investig Clin Den 2011; 3: 162-170.
42. AL-Bayaty FH, Taiyeb-Ali TB, Abdulla MA, Mahmud ZB. Antibacterial effects of Oradex, Gengigel and Salviathymol-n mouthwash on dental biofilm bacteria. Afr J Microbiol Res 2011;5(6): 636-642.
43. Dudic VB, Lang NP, Mombelli A. Microbiological and clinical effects of an antiseptic dental varnish after mechanical periodontal therapy. J Clin Periodontol. 1999; 26:341-346.
44. Venkatesh A, Ramamurthy J. Local drug delivery systems in the treatment of periodontitis - An Overview. Int J Pharm Pharm Sci, 2012; 4: 30-37.
45. Agarwal E, Pradeep AR, Bajaj P, Naik SB. Efficacy of local drug delivery of 0.5 % clarithromycin gel as an adjunct to nonsurgical periodontal therapy in the treatment of chronic periodontitis subjects among smokers - A randomized controlled clinical trial. DOI: 10.1902/jop.2012.110600.
46. Kukreja BJ, Dodwad V. Herbal Mouthwashes - A Gift Of Nature: Int J Pharm Bio Sci 2012; 3: 46-52.
47. Bansal S, Rastogi S, Bajpai M. Mechanical, Chemical and Herbal Aspects of Periodontitis: A Review. Int J Pharm Sci Res 2012; 3(5): 1260-1267.
48. Shah N. Local delivery of antimicrobial agents in periodontal therapy. J Indian Soc Periodontol 1999; 2:26-29.
49. Nakahara T, Nakamura T, Kobayashi E, Inoue M, Shigeno K et al. Novel Approach to Regeneration of Periodontal Tissues Based on in Situ Tissue Engineering: Effects of Controlled Release of Basic Fibroblast Growth Factor from a Sandwich Membrane. Tissue Engineering 2003, 9(1): 153-162.
50. Prajapati J, Patel H, Agrawal YK. Targeted drug delivery for central nervous system: a review. Int J Pharm Pharm Sci 2012; 4(3): 32-38.